Here's Why NuVasive Is Tanking Today
After NuVasive (NASDAQ: NUVA), a medical device maker focused on minimally invasive spine surgery, reported mixed second-quarter earnings results and announced a shake-up in its executive team, its shares had fallen 11% as of 11:45 a.m. EDT.
Here's a quick review of the headline numbers from NuVasive's second quarter:
While the slight miss on revenue could help to explain the sell-off, the markets were caught off guard by the announcement of sweeping changes to the company's executive team:
Source: Fool.com
Johnson & Johnson Stock
€141.58
4.520%
With 32 Buy predictions and 1 Sell predictions Johnson & Johnson is one of the favorites of our community.
As a result the target price of 196 € shows a positive potential of 38.44% compared to the current price of 141.58 € for Johnson & Johnson.
